Tiina E. Kahkonen
Oulu, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Insights into immuno-oncology drug development landscape with focus on bone metastasis.
Journal: Frontiers in immunology
Published: December 12, 2022
Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis.
Journal: Cells
Published: April 14, 2021
Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: September 17, 2020
Critical evaluation of the subcutaneous engraftments of hormone naïve primary prostate cancer.
Journal: Translational andrology and urology
Published: July 18, 2020
Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development.
Journal: Cancers
Published: April 30, 2020
Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model.
Journal: Journal of bone oncology
Published: January 08, 2019
Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone.
Journal: Journal of immunology research
Published: October 24, 2018
Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes.
Journal: Molecular and cellular endocrinology
Published: March 12, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026